Metraipolis › archive › dc_74e6eb0392ef

The Therapeutic Potential of Purmorphamine Across Disease Models — Europe PMC PMID:42698179

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42698179
DOI
10.1111/jcmm.71349
License (as archived)
solo-consultazione
Archived
2026-10-16T07:40:28.978Z
SHA-256 of the archived text
3575f2a4c736f4cc4e59383fdc09bb1ba683b297726f36a80b39daa55eb06e40
Stable URL of this page
https://metraipolis.com/documento/dc_74e6eb0392ef

How to cite

The Therapeutic Potential of Purmorphamine Across Disease Models — Europe PMC PMID:42698179 — Europe PMC (en), https://europepmc.org/article/MED/42698179 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_74e6eb0392ef (Metraipolis archive dc_74e6eb0392ef, sha256 3575f2a4c736f4cc4e59383fdc09bb1ba683b297726f36a80b39daa55eb06e40)
BibTeX
@misc{dc74e6eb0392ef,
  title = {The Therapeutic Potential of Purmorphamine Across Disease Models — Europe PMC PMID:42698179},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42698179},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_74e6eb0392ef; sha256 3575f2a4c736f4cc4e59383fdc09bb1ba683b297726f36a80b39daa55eb06e40},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42698179. Agents can read the archived copy with the MCP tool read_document.